The landscape of antibody therapeutic development is undergoing a profound transformation, driven by the accelerating integration of artificial intelligence (AI)…
Read More
The biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
The past two weeks have witnessed a significant acceleration in the biopharmaceutical landscape, marked by a flurry of strategic partnerships…
Read More
Professor Peter Tessier Pioneers AI-Driven Solutions for Antibody Deliverability Challenges
In a significant advancement for pharmaceutical sciences, Professor Peter Tessier, the esteemed Albert M. Mattocks Professor of Pharmaceutical Sciences and…
Read More
Oxford Professor Unveils AI Software Humatch for Rapid, Gene-Specific Antibody Humanization, Revolutionizing Therapeutic Development
Oxford, UK – In a significant stride for pharmaceutical innovation, Professor Charlotte Dean, a leading figure in Structural Bioinformatics at…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says.
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a groundbreaking application designed to revolutionize the speed…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a groundbreaking application poised to revolutionize drug discovery…
Read More
Scientists Pioneer World’s First Human Antibody Treatment for Measles, Offering Critical Defense Amid Global Resurgence
In a groundbreaking development that promises to reshape the global fight against measles, scientists at the La Jolla Institute for…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
Amazon Web Services (AWS) today unveiled Amazon Bio Discovery, a groundbreaking application designed to drastically accelerate the drug discovery process…
Read More
Amazon Bio Discovery Cuts MSK Antibody Design from a Year to Weeks, AWS Says
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a sophisticated application designed to significantly accelerate the…
Read More
Daiichi Sankyo Partners with Waiv to Accelerate Digital Pathology Biomarker Discovery for Antibody-Drug Conjugate Programs
In a strategic move to enhance precision in oncology drug development, Japanese pharmaceutical giant Daiichi Sankyo has announced a significant…
Read MoreYOU MAY HAVE MISSED
